SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000882104-19-000074
Filing Date
2019-06-24
Accepted
2019-06-24 21:41:57
Documents
1
Period of Report
2019-06-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_156142690185407.html 4  
1 FORM 4 wf-form4_156142690185407.xml 4 3727
  Complete submission text file 0000882104-19-000074.txt   5172
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Issuer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address
Hernday Natasha (Reporting) CIK: 0001780547 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19756 | Film No.: 19916761